Systemic Delivery of AAV-Fdxr Mitigates the Phenotypes of Mitochondrial Disorders in Fdxr Mutant Mice

Gene therapy now provides a novel approach for treating inherited monogenetic disorders, including nuclear gene mutations associated with mitochondrial diseases. In this study, we have utilized a mouse model carrying a p.Arg389Gln mutation of the mitochondrial Ferredoxin Reductase gene (Fdxr) and tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li, Slone, Jesse, Zou, Weiwei, Queme, Luis F., Jankowski, Michael P., Yin, Fei, Huang, Taosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488755/
https://www.ncbi.nlm.nih.gov/pubmed/32995353
http://dx.doi.org/10.1016/j.omtm.2020.05.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488755/
https://www.ncbi.nlm.nih.gov/pubmed/32995353
http://dx.doi.org/10.1016/j.omtm.2020.05.021

Ejemplares similares